Opie L H
Am J Cardiol. 1985 Apr 26;55(10):95D-100D. doi: 10.1016/0002-9149(85)91062-8.
During normal exercise the myocardium, skeletal muscle, liver and adipose tissue all participate in the metabolic response to exercise. Beta-blockade, by impairing this biochemical-metabolic response at several levels, limits the capacity for maximal exercise. The relevant effects of beta blockade may include hypoglycemia, impaired mobilization of free fatty acids and decreased breakdown of glycogen in skeletal muscle. The organs responsible for these metabolic changes are the liver (blood sugar), adipose tissue (blood free fatty acids) and skeletal muscle. Most of the metabolic beta-adrenergic receptors are thought to be beta 2 in nature. Two populations of receptors (mixed beta 1 and beta 2) may explain some controversial findings. Overall, the data suggest that cardioselective agents may have less effect than nonselective agents in producing metabolic impairment during sustained exercise.
在正常运动期间,心肌、骨骼肌、肝脏和脂肪组织均参与对运动的代谢反应。β受体阻滞剂通过在多个水平损害这种生化代谢反应,限制了最大运动能力。β受体阻滞剂的相关作用可能包括低血糖、游离脂肪酸动员受损以及骨骼肌中糖原分解减少。负责这些代谢变化的器官是肝脏(血糖)、脂肪组织(血中游离脂肪酸)和骨骼肌。大多数代谢性β肾上腺素能受体被认为本质上是β2受体。两类受体(β1和β2混合)可能解释了一些有争议的发现。总体而言,数据表明在持续运动期间,心脏选择性药物在产生代谢损害方面的作用可能小于非选择性药物。